Marc E. Agronin, MD
Vice President for Behavioral Health and Clinical Research
Miami Jewish Health Systems
Affiliate Associate Professor of Psychiatry and Neurology
University of Miami Miller School of Medicine
Bradford C. Dickerson, MD
Associate Professor of Neurology, Harvard Medical School
Director, Frontotemporal Disorders Unit
Behavioral Neurologist, Alzheimer’s Disease Research Center,
Massachusetts General Hospital
This live activity is focused on the early diagnosis and management of Alzheimer’s disease.
This activity is designed to meet the educational needs of neurologists, psychiatrists, internal medicine and family practitioners, and other HCPs (MDs, DOs, NPs, PAs, clinical nurse specialists, etc.) who are involved in the assessment and care of patients with cognitive impairment.
After completing the CME activity, learners should be better able to:
- Recognize the importance of an early differential diagnosis of Alzheimer’s disease to allow for early disease management or referral
- Describe current understanding of AD pathophysiology and review the use of cognitive and neuroimaging tests as part of a comprehensive evaluation for the early diagnosis of mild Alzheimer’s disease
- Discuss current and emerging therapeutic targets, and new data on investigational agents for treatment of mild AD with a disease-modifying approach to delay or slow AD progression
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 2.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with AD.
Credits: 2.0 ANCC Contact Hours
CNE Accreditation Statement: Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 3.0 contact hours of continuing nursing education of RNs and APNs.
Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this program qualifies for up to 2 contact hours. Full attendance is required. No partial contact hours will be awarded for partial attendance.
Pharmacist participants – Please be sure to provide your NAB ID and DOB for ACPE credit processing.
This program has been reviewed and is approved for a maximum of 2.00 hours of AAPA Category 1 CME credit by the Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity.
This program was planned in accordance with AAPA’s CME Standards for Enduring Programs and for Commercial Support of Enduring Programs.
The American Osteopathic Association (AOA) Council on Continuing Medical Education has APPROVED this activity for 2 AOA Category 2-A credits.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Dr. Dickerson is a consultant for Merck, Lilly, and Biogen. He receives royalties from Oxford University Press and Cambridge University Press.
Dr. Agronin is on the Speakers’ Bureau for Allergan. He is a consultant for Eli Lilly and receives royalties from Rowan Littlefield and Tylor & Francis for books on dementia. He also has performed research for Eli Lilly, Biogen, Elsai, vTv Therapeutics, Hoffman La Roche, Axovant, Otsuka, Intracellular, Enzymotec, Genetech, Neurim, and Acadia.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
UMA/CCM Nurse Reviewer – – Melinda Chang, NP has nothing to disclose
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lisa Crenshaw Senior Program Manager for Med Learning Group has nothing to disclose.
Flavia Piazza, PhD, VP Medical and Scientific Services for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this live activity. To receive CME/CNE credit participants must:
- 1. Read the CME/CNE information and faculty disclosures.
- 2. Participate in the live activity.
- 3. Submit the evaluation form to the Med Learning Group.
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
You will receive your certification via email within 30 days.
For CME questions, please contact: Med Learning Group at email@example.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.). Please contact Med Learning Group prior to the live event at firstname.lastname@example.org
RELEASE DATE: June 5, 2017
EXPIRATION DATE: June 5, 2018
Estimated Time to Complete This Educational Activity: 60 minutes
This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.
Copyright © 2017 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.